Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yew Fong, Chun"'
Autor:
Oh, Danielle H., MA, Xiao, He, Jackson, Kearney, Conor, Hogg, Simon J., Newbold, Andrea, Fraser, Peter, Jennings, Ian G., Brasacchio, Daniella, Susanto, Olivia, Yew Fong, Chun, Dawson, Mark A., Gruber, Emily, Kats, Lev, Johnstone, Ricky W., Thompson, Philip E., Shortt, Jake
Publikováno v:
HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Autor:
Bell, Charles C, Fennell, Katie A, Chan, Yih-Chih, Rambow, Florian, Yeung, Miriam M, Vassiliadis, Dane, Lara, Luis, Yeh, Paul, Martelotto, Luciano G, Rogiers, Aljosja, Kremer, Brandon E, Barbash, Olena, Mohammad, Helai P, Johanson, Timothy M, Burr, Marian L, Dhar, Arindam, Karpinich, Natalie, Tian, Luyi, Tyler, Dean S, MacPherson, Laura, Shi, Junwei, Pinnawala, Nathan, Yew Fong, Chun, Papenfuss, Anthony T, Grimmond, Sean M, Dawson, Sarah-Jane, Allan, Rhys S, Kruger, Ryan G, Vakoc, Christopher R, Goode, David L, Naik, Shalin H, Gilan, Omer, Lam, Enid YN, Marine, Jean-Christophe, Prinjha, Rab K, Dawson, Mark A
Non-genetic drug resistance is increasingly recognised in various cancers. Molecular insights into this process are lacking and it is unknown whether stable non-genetic resistance can be overcome. Using single cell RNA-sequencing of paired drug naïv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::669f8884269e1d2de07b751fa8d013ca
Autor:
Bell CC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Fennell KA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Chan YC; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Rambow F; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium., Yeung MM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Vassiliadis D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lara L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Yeh P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Martelotto LG; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Rogiers A; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Kremer BE; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Barbash O; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Mohammad HP; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Johanson TM; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Burr ML; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Dhar A; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Karpinich N; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Tian L; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Tyler DS; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., MacPherson L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Shi J; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., Pinnawala N; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Yew Fong C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Grimmond SM; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Dawson SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia., Allan RS; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Kruger RG; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA., Goode DL; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Naik SH; The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia., Gilan O; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Lam EYN; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Marine JC; Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology, KU Leuven, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Prinjha RK; Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Dawson MA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.; Centre for Cancer Research, University of Melbourne, Melbourne, VIC, Australia. Mark.Dawson@petermac.org.
Publikováno v:
Nature communications [Nat Commun] 2019 Jun 20; Vol. 10 (1), pp. 2723. Date of Electronic Publication: 2019 Jun 20.